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Dematiaceous molds are increasingly recognized as important human pathogens. We report 2 cases of cutaneous phaeohyphomycosis in
renal allograft recipients, caused by Alternaria alternata and Curvularia spp., respectively, which demonstrate the diversity in clinical
presentation, the different therapeutic strategies, and the clinical importance of azole antifungal-induced drug–drug interactions with
immunosuppressive therapy.
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Phaeohyphomycosis is a heterogeneous group of oppor-
tunistic infections caused by dematiaceous molds, which are
ubiquitous in nature, but rarely cause human disease (Naggie
and Perfect, 2009; Pastor andGuarro, 2008; Revankar, 2006).
However, due to the growing populations of immunocom-
promised patients, including solid organ transplant recipients,
these fungi are increasingly recognized as important human
pathogens (Ben-Ami et al., 2009; Boyce et al., 2009; Ogawa
et al., 2009). We recently encountered 2 cases of phaeohy-
phomycosis in renal allograft recipients, which demonstrate
that the clinical presentation can be very different from 1
patient to the other and that different therapeutic strategies
can be adopted (Naggie and Perfect, 2009; Revankar, 2006;
2007). Moreover, these cases highlight the clinical impor-
tance of azole antifungal-induced drug–drug interactions
with immunosuppressive therapy in this specific patient
population (Kuypers et al., 2006; Mori et al., 2009). Finally,
in 1 case, the skin lesions were caused by Curvularia spp.,
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organ transplant recipient (Tessari et al., 2003).2. Case reports
The first case is a 51-year-old woman of Russian origin
who presented at the outpatient clinic 3 months after kidney
transplantation with a small red pustule on her right knee. At
that time, she was treated with tacrolimus, mycophenolate
mofetil and methylprednisolone. She did not recall any local
skin trauma occurring since transplantation. The lesion
rapidly enlarged to a large violaceous reddish indurated 4 ×
3-cm plaque with a central ulcer (Fig. 1A). Diagnosis of
phaeohyphomycosis caused by Alternaria alternata was
established based on a culture of a skin biopsy on Sabouraud
agar (incubation at 35 °C for 2 days and at 30 °C afterward),
on which the organisms appeared gray–black and woolly in
texture (Fig. 2A). The fungus was subcultured on Takashio
medium for stimulation of sporulation. Microscopic analysis
showed presence of large (±10–25 μm) medium brown
conidia with a clublike shape and both transverse and
longitudinal septations and a short beak (Fig. 2B). A
magnetic resonance imaging (MRI) of the right knee showed
subcutaneous spreading of the infection (2.1 × 2.7 × 0.4 cm)
but no invasion of deeper tissue (Fig. 1B). A complete
Fig. 1. (A) Case 1: skin lesion on the right knee caused by A. alternata: large
violaceous reddish indurated plaque with central ulcer. (B) Case 1: T2-
weighted MRI image of right knee showing a subcutaneous hyper intense
zone (arrow, 2.1 × 2.7 × 0.4 cm): subcutaneous spreading of A. alternata
infection, no invasion of deeper tissue.
ig. 2. (A) Macroscopic appearance of cultured A. alternata: typical gray–
lack color and wooly texture. (B) Microscopic appearance of cultured A.
lternata: typical golden brown coloring of the cell walls and hyphae
aused by melanin pigments, presence of large medium brown conidia
ith a clublike shape and both transverse and longitudinal septations, and
short beak.
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thickness skin graft was used to replace the excised skin.
Voriconazole tablets 200 mg bid were started before surgery
and continued for 3 months. During voriconazole therapy,
there was a drastic decrease in tacrolimus dose requirements
from 11 to 1.5 mg bid. Toxic tacrolimus levels were avoided
using preemptive tacrolimus dose reductions. Currently,
more than 6 months after discontinuation of voriconazole,
there are no signs of disease recurrence, and tacrolimus dose
requirements are 6.5 mg bid.
The second case is a 71-year-old male renal allograft
recipient treated with tacrolimus, mycophenolate mofetil,
and methylprednisolone. Two years after kidney transplan-
tation, he developed 2 painless erythematous nodules on thedorsum of the right hand (0.5 cm) (Fig. 3A) and the right
ankle (1.5 cm). In this case, there was no history of skin
trauma either. The lesion on the ankle slowly enlarged over a
6-week period and eventually became a small ulcer (Fig.
3B). A punch biopsy specimen was taken from both lesions
for histologic examination and culture on Sabouraud agar
and subsequent subculture on diluted Sabouraud agar.
Microscopic evaluation showed dark brown slightly curved
conidia in which the central cells appeared darker than the
end cells and in which only transverse but no longitudinal
septations were present. Based on these characteristics, the
pathogen was identified as Curvularia spp. Itraconazole
capsules 200 mg bid were started. Because of the slow
progression of the lesions, no surgery was planned. Despite
tapering of the tacrolimus dose, tacrolimus concentrations
increased significantly. This was accompanied by severe
headache, nausea, anorexia, and weight loss. After reducing
tacrolimus dose from 1 mg bid (before start of itraconazole)






Fig. 3. (A) Case 2: skin lesion on the dorsum of the right hand caused by Curvularia spp.: erythematous nodule with crust. (B) Case 2: skin lesion on the right
ankle caused by Curvularia spp.: erythematous nodule evolving to a small ulcer. (C) Case 2: healed skin lesion on the dorsum of the right hand. (D) Case 2:
healed skin lesion on the right ankle.
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Although the lesion on the ankle healed without any surgical
intervention, the lesion on the hand needed to be excised
because of lack of improvement after 4 months of
itraconazole therapy. Itraconazole was continued for 6
months, and no relapse has occurred since (Fig. 3C and D).3. Discussion
Phaeohyphomycoses are rare opportunistic fungal infec-
tions predominantly affecting the skin (Boyce et al., 2009;
Ogawa et al., 2009), though systemic disease and dissem-
inated infection can occur (Ben-Ami et al., 2009; Naggie and
Perfect, 2009; Pastor and Guarro, 2008; Revankar, 2006).
Phaeohyphomycosis has been attributed to more than 100
different species of dematiaceous molds including Alter-
naria and Curvularia spp., which were the causative
pathogens in the presented cases (Ben-Ami et al., 2009;
Naggie and Perfect, 2009; Ogawa et al., 2009; Revankar,2007). In solid organ transplant recipients, phaeohyphomy-
cosis caused by Alternaria spp. has been reported in several
case reports and small patient series (Boyce et al., 2009;
Farina et al., 2007; Ogawa et al., 2009; Segner et al., 2009).
However, reports of phaeohyphomycosis caused by Curvu-
laria spp. in this population are rare. Though cases have been
reported in patients treated for hematologic malignancies/
bone marrow transplant recipients (Ben-Ami et al., 2009;
Berlanga et al., 1995; Bonduel et al., 2001); to our
knowledge, only 1 such case has been reported in a solid
organ transplant recipient thus far (Tessari et al., 2003).
Diagnosis of phaeohyphomycosis is complicated by its
highly variable clinical presentation (Ben-Ami et al., 2009;
Boyce et al., 2009; Ogawa et al., 2009). Moreover, in
contrast to other more common mycoses, no simple
serologic or antigen tests exist to detect phaeohyphomycosis
in blood or tissue. Therefore, a biopsy for histologic
examination and culture are of critical importance to
establish a diagnosis (Ben-Ami et al., 2009; Boyce et al.,
2009; Naggie and Perfect, 2009). As mortality of invasive
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degree of clinical suspicion in transplant recipients with skin
lesions and to start treatment promptly.
Unfortunately, treatment is not standardized (Ben-Ami et
al., 2009; Boyce et al., 2009; Ogawa et al., 2009; Revankar,
2006; Yehia et al., 2004). As most of the dematiaceous
molds are susceptible to triazoles, including itraconazole and
voriconazole, which were used in the presented cases, these
drugs are the cornerstone of treatment of phaeohyphomy-
cosis (Lai et al., 2008; Naggie and Perfect, 2009; Patterson,
2005; Revankar, 2006). However, there is no formal
consensus which specific agent to use and the ideal duration
of therapy because clinical trials are lacking (Ben-Ami et al.,
2009; Naggie and Perfect, 2009; Revankar, 2006). Surgery is
probably the best treatment of well delineated lesions (Boyce
et al., 2009; Farina et al., 2007; Ogawa et al., 2009), but even
when excision is complete, additional medical treatment is
advocated to avoid local sporotrichoid dissemination and to
treat concomitant subclinical lesions (Boyce et al., 2009;
Farina et al., 2007). In selected patients, cure can be achieved
with medical treatment alone, as demonstrated in the second
case in which one of the lesions healed without excision
(Farina et al., 2007; Naggie and Perfect, 2009).
One of the major points to consider using broad
spectrum azoles in allograft recipients is that these drugs
are strong CYP3A4/5 inhibitors and may cause major
drug–drug interactions with several immunosuppressive
agents including the frequently used calcineurin inhibitors
cyclosporine and tacrolimus and the mTOR inhibitors
sirolimus and everolimus (Kuypers et al., 2006; Mori et
al., 2009; Surowiec et al., 2008). As these immunosup-
pressive drugs are characterized by a narrow therapeutic
window, these drug–drug interactions could lead to
clinical complications as also clearly demonstrated in the
second case. Hence, close monitoring of tacrolimus
concentrations and clinical alertness for signs of drug-
related toxicity are mandatory. Moreover, when azole
therapy is discontinued, it is important to maintain strict
monitoring of these patients as failure to timely adjust
tacrolimus dosing could result in underexposure and risk
of acute graft rejection.
In conclusion, clinicians involved in solid organ trans-
plantation should always consider the possibility of
phaeohyphomycosis in allograft recipients presenting with
skin lesions as a high degree of clinical suspicion is essential
to allow timely initiation of a correct diagnostic and
therapeutic workup.References
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